Dr. Marcel Martin presented recent advances in the radiosynthesis and preclinical evaluation of ¹⁸F-Flutrahexin radiolabeled via the TetraKit platform for αvβ6-positive tumors, such as pancreatic cancer. The 18F-labeled tracer performs on par with ⁶⁸Ga-Trivehexin and offers promising opportunities for high-resolution PET imaging and theranostic applications with ¹³¹I and ²¹¹At.
The TetraKit team looks forward to continuing to advance in nuclear medicine and sharing latest achievements ☢️
